Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis

Clinical trial NCT05177939 · UNKNOWN

Trial details

NCT number: NCT05177939
Sponsor: Nihon Pharmaceutical Co., Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Autoimmune Encephalitis

Start date: 2022-03-03
Primary completion: 2024-05-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.